Pre-habilitation of Patients Scheduled for Cardiac Valve Surgery

NCT ID: NCT03571906

Last Updated: 2018-06-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

25 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-07-31

Study Completion Date

2019-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Cardiac rehabilitation (CR) is an integral part of cardiovascular disease management incorporating aspects of scientifically constructed appropriate physical exercise. CR has been repeatedly shown to significantly improve functional capacity, depression and wellbeing, even following short term interventions. Functional capacity is closely related to frailty, a key prognostic factor in subjects undergoing cardiac surgery. We intend to enroll 50 stable subjects with valvular heart disease scheduled for surgical intervention. Our hypothesis is that the Prehab group will improve their functional capacity to a greater degree than the usual care group, possibly associated with better clinical outcomes.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Cardiac rehabilitation (CR) is an integral part of cardiovascular disease management incorporating aspects of scientifically constructed appropriate physical exercise, dietary intervention, secondary prevention by pharmacotherapy, and psychological intervention. CR has been repeatedly shown to significantly improve functional capacity, depression and wellbeing, even following short term interventions (6-8 weeks in accordance with the date of surgery determined for the patient.) Functional capacity is closely related to frailty, a key prognostic factor in subjects undergoing cardiac surgery. Small studies have demonstrated possible benefits of pre-habilitation - a multidisciplinary intervention aimed at improving frailty in the weeks prior to surgery.

We intend to enroll 50 stable subjects with valvular heart disease scheduled for surgical intervention. Following a comprehensive clinical and physiological evaluation subjects will be randomized (1:1) to a Prehab arm (PHB) vs. usual care (UC). Subjects in the prehab arm will receive a hybrid institution and home-based exercise prescription, nutritional and psychological intervention and periodic calls. Adherence will be assessed and encouraged by smartwatch and matching smartphone software. In the usual care arm subjects will receive general recommendations following the baseline stress test performed by both groups (prehab is not standard of care or guideline based). Another stress test will be performed days prior to valve surgery.

Our hypothesis is that the Prehab group will improve their functional capacity to a greater degree than the usual care group, possibly associated with better clinical outcomes.

The primary efficacy outcome will be exercise capacity (assessed by symptom limited stress test - estimated METS) change from baseline (enrollment) to pre-surgery evaluation visit (pre-op test).

Secondary measures:

Compare the 2 study arms in regard to:

1. Length of ICU and hospital stay
2. Perioperative adverse events
3. 30-day mortality or re-hospitalization
4. QOL and satisfaction

Patient / Group numbers: A total of 50 patients with established valvular disease will be enrolled to PHB or UC after eligibility verification by cardiothoracic surgeon

Hardware: Standard off the shelf Polar sports watch (M430) with matching smartphone software. No clinical or identifiable data will be inputted into these systems (coded subject ID only).

Clinical data and the entire program will be managed through the hospital electronic medical record (EMR). All clinical decisions \\ recommendations and events will be recorded in the EMR.

Intervention: Patients will be randomized to pre-operative usual care or rehabilitation program comprising of on-site (Sheba MC) and off-site training sessions. Adherence to the rehab program will be assessed and a structured motivational program and follow-up will be provided in order to maximize goal completion.

Following the standard rehabilitation intake process (stress test, physician visit, nurse intake), the subjects in the prehab arm will receive physiologic consultation based on clinical stress tests and clinical data passed from the physician. Subjects in the prehab arm will receive an exercise prescription and execution will be assessed and periodically adjusted in accordance to data received from the wearable device. Intensity and type of exercise will be moderate and will comply with exercise recommendations provided by ESC guidelines. A dedicated application will be installed on the mobile phone for patients in the research group and they will receive a smart sports watch.

Periodic encouragements and consultations will be provided by exercise trainer, physiologist and nurse from the cardiac rehabilitation center. A physician will be available for consultations.

In addition to monitored physical activity, patients will receive nutritional and psychological counseling. This is part of a multi-professional rehabilitation program accepted by the rehabilitation center.

The control group will receive recommendations for a healthy and active lifestyle and physician follow-up

All subjects will undergo a stress test at baseline post enrollment and again prior to surgery.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Valvular Heart Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Pre-rehab intervention

Subjects in the prehab arm will receive an exercise prescription and execution will be assessed and periodically adjusted in accordance to data received from the wearable device. Intensity and type of exercise will be moderate and will comply with exercise recommendations provided by ESC guidelines. A dedicated application will be installed on the mobile phone for patients in the research group and they will receive a smart sports watch.

Periodic encouragements and consultations will be provided by exercise trainer, physiologist and nurse from the cardiac rehabilitation center. A physician will be available for consultations.

In addition to monitored physical activity, patients will receive nutritional and psychological counseling. This is part of a multi-professional rehabilitation program accepted by the rehabilitation center.

Group Type EXPERIMENTAL

Tele - Cardiac Pre-Rehabilitation

Intervention Type BEHAVIORAL

We intend to enroll 50 stable subjects with valvular heart disease scheduled for surgical intervention. Following a comprehensive clinical and physiological evaluation subjects will be randomized (1:1) to a Prehab arm (PHB) vs. usual care (UC). Subjects in the prehab arm will receive a hybrid institution and home-based exercise prescription, nutritional and psychological intervention and periodic calls. Adherence will be assessed and encouraged by smartwatch and matching smartphone software. In the usual care arm subjects will receive general recommendations following the baseline stress test performed by both groups (prehab is not standard of care or guideline based). Another stress test will be performed days prior to valve surgery Adherence to the rehab program will be assessed and a structured motivational program and follow-up will be provided in order to maximize goal completion.

pre-operative usual care arm

The control group will receive recommendations for a healthy and active lifestyle and physician follow-up

All subjects will undergo a stress test at baseline (post enrollment), and again prior to cardiac surgery.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Tele - Cardiac Pre-Rehabilitation

We intend to enroll 50 stable subjects with valvular heart disease scheduled for surgical intervention. Following a comprehensive clinical and physiological evaluation subjects will be randomized (1:1) to a Prehab arm (PHB) vs. usual care (UC). Subjects in the prehab arm will receive a hybrid institution and home-based exercise prescription, nutritional and psychological intervention and periodic calls. Adherence will be assessed and encouraged by smartwatch and matching smartphone software. In the usual care arm subjects will receive general recommendations following the baseline stress test performed by both groups (prehab is not standard of care or guideline based). Another stress test will be performed days prior to valve surgery Adherence to the rehab program will be assessed and a structured motivational program and follow-up will be provided in order to maximize goal completion.

Intervention Type BEHAVIORAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Pre-rehab program

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Valvular heart disease and planed surgery within the next 4-12 weeks
* Age ≥ 21
* Smartphone with internet connection
* Willing and able to comply with study protocol and
* Able to follow the personalized exercise prescription, utilize Polar watch and upload exercise data per protocol

Exclusion Criteria

* Advanced Heart failure (NYHA \>3) or unresolved significant arrhythmia (i.e. symptomatic atrial fibrillation)
* Significant neurological or cognitive impairment
* Women of child-bearing potential
* Symptomatic hypotension, orthostatic hypotension or repeated blood pressure systolic value \<100 mmHg without symptoms
* ACS or percutaneous coronary intervention (PCI) within 30 days prior to screening, or having undergone CABG surgery within 30 days prior to screening
* Inability to perform a stress test due to physical limitations
* Severe angina pectoris as defined by CCS \>2
* Pulmonary disease of severity greater than mild (COPD, Asthma, ILD, CTD with lung involvement) or chronic pulmonary thromboembolic disease (CTED)
* Severe orthopedic limitations not permitting exercise
* Active myocarditis, constrictive pericarditis, restrictive or hypertrophic cardiomyopathy
* Significant anemia (Hb \< 9 mg/dl)
* Known drug or alcohol dependence or any other factors which will interfere with the study conduct or interpretation of the results or in the opinion of the investigator are not suitable to participate;
* Any illness which reduces life expectancy to less than 1 year from screening
Minimum Eligible Age

21 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Sheba Medical Center

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dr. Robert Klempfner Heart Rehabilitation Institute

Prof. Klempfner

Responsibility Role PRINCIPAL_INVESTIGATOR

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Robert Klempner, Prof.

Role: CONTACT

97235303068

Merav Moreno

Role: CONTACT

97235303068

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

4517-17-SMC

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.